Lv22
190 积分 2021-11-19 加入
Intravitreal aflibercept 8 mg in neovascular age-related macular degeneration (PULSAR): 48-week results from a randomised, double-masked, non-inferiority, phase 3 trial
5小时前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
3个月前
已完结
Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study
4个月前
已完结
Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China
4个月前
已完结
Anti-vascular endothelial growth factor for neovascular glaucoma
4个月前
已完结
Anti-vascular endothelial growth factor for neovascular glaucoma
4个月前
已完结
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity
4个月前
已完结
[Research progress of treatment strategies for choroidal neovascularization secondary to pathological myopia]
4个月前
已完结
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy
4个月前
已完结
Use of Maribavir for Multidrug Resistant Cytomegaloviremia in a Pediatric Oncology Patient
10个月前
已完结
皖公网安备34019202002308
